Englebert Financial Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305K Sell
2,373
-496
-17% -$58.1K 0.3% 50
2026
Q1
$345K Sell
2,869
-5,714
-67% -$660K 0.39% 42
2025
Q4
$903K Buy
+8,583
New +$806K 1.03% 19

Other funds holding MRK

Englebert Financial Advisers's MRK Position: Q2 2026 in Review

Englebert Financial Advisers reduced its Merck (MRK) stake by 17% in Q2 2026, selling an estimated $58.1K and leaving 2,373 shares worth $305K. The position accounts for 0.3% of the portfolio, ranked #50.

Englebert Financial Advisers first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $903K in Q4 2025. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Englebert Financial Advisers held 2,373 shares of Merck worth $305K as of Q2 2026.
  • Englebert Financial Advisers sold 496 Merck shares in Q2 2026, an estimated $58.1K.
  • Merck made up 0.3% of Englebert Financial Advisers's portfolio in Q2 2026, its #50 holding.
  • Englebert Financial Advisers first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • Englebert Financial Advisers's Merck position peaked at $903K in Q4 2025.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Englebert Financial Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.